obesity drug news today glp-1 drugs Market Overview: GLP-1 Agonists and the Obesity Market New Guidelines on GLP-1 Drugs

Some studies have reported that depression caused by chronic stress disrupts the BDNFtropomyosin related kinase B (TrkB) receptor signaling pathway in the PFC and hippocampus, and ultimately contributes to impaired synaptic maturation, synaptic protein synthesis, and glutamate receptor cycling ( Therefore, because neurotransmitter imbalance contributes to depressive behaviors in patients with depression as described above, the appropriate modulation of neurotransmitters in the brain is key to treating depression ( Figure 2 )

Rosenstock J, Kahn SE, Johansen OE, Zinman B, Espeland MA, Woerle HJ, et al

In order to close a knowledge gap regarding the relationship between metabolism and reproduction, the study investigates the effects of GLP-1 on the reproductive axis in healthy men (105) Enrolling eighteen fit male subjects ensured they were free of mental or physical illnesses and did not use prohibited substances

My dear sweet son

The most significant is the restricted number of included studies